President Donald Trump’s budget proposal includes rolling a relatively obscure agency that conducts health care research into the National Institutes of Health, and cutting the NIH budget by $5.8 billion.
That small agency – the Agency for Healthcare Research and Quality, or AHRQ (pronounced “arc“) – could be cut entirely or see its mission shrink drastically under the president’s plan. Reducing or eliminating AHRQ would have a significant effect on health system research and health IT adoption in communities across the country. Reporters have a number of ways to see how changes to AHRQ could affect health services in their region. Continue reading
The potential benefits of genetic testing are widely touted and drive greater interest in these tests – even though the validity of the science behind such testing remains unclear.
Charles Piller, the West Coast editor for Boston-based online news site Stat, recently reported on the lack of a firm scientific basis for a test that Proove Biosciences in Irvine, Calif., has been marketing as an “opioid risk” detector. Continue reading
For the AHCJ Fellowship on Comparative Effectiveness Research, a select group of fellows will be chosen to spend a week in Washington, D.C., focused on understanding and reporting on medical research.
Joe Carlson, one of last year’s fellows, said the fellowship was, “Educational and practical – you don’t always get that. This was well worth my time.”
Applications are due no later than Monday, Aug. 1. Sessions will help fellows: Continue reading
At Health Journalism 2016 in Cleveland, Andrew M. Seaman and Hilda Bastian discussed shortcuts for weighing the likelihood a study’s answer is right, making sense of shifting bodies of evidence and cutting through researcher spin. Continue reading
Each year, the AHCJ conference includes a smorgasbord of opportunities to inform and enhance journalists’ knowledge and reporting. Topics include health care disparities, hospital performance reporting, age-specific conditions for youth and elderly alike – and, of course, what the medical research reveals about these and other subjects.
Even in sessions that focus on a specific population or a condition that doesn’t immediately seem relevant to medical research – such as how to cover the ongoing opioid epidemic – there likely are ways that the material intersects with research on that topic. If you’re looking for stories that might involve some digging in PubMed, here are some sessions to consider during Health Journalism 2016 in Cleveland, April 7-10. Continue reading
Siobhan O’Connor recently explored in a Time magazine piece an issue that has been gaining traction in both the medical world and the media reporting on it: the overtreatment of breast cancer.
Her story, “Why Doctors Are Rethinking Breast-Cancer Treatment,” opens with an anecdote from now-60-year-old Desiree Basila, who several years ago decided to do … nothing after receiving a diagnosis of ductal carcinoma in situ (DCIS), a stage 0 cancer in the breast ducts that was not invasive – and may never become so. What makes this opening anecdote striking was not simply Basila’s decision – one that has been discussed more often in recent years – but when it occurred: Continue reading